Poly Medicure Limited Announces Unaudited Standalone Fourth Quarter and Full Year and Audited Consolidated Earnings Results for the Full Year March 31, 2012; Recommends Dividend for the Fiscal 2012; Announces Induction of Shri Shailendra Raj Mehta as an Additional Director in the Capacity of Non Executive, Independent Director on the Board
May 28, 2012
Share
Poly Medicure Limited announced unaudited standalone fourth quarter and full year and audited consolidated earnings results for the full year March 31, 2012. For the quarter, on standalone basis, the company reported profit from operations before other income, finance costs and exceptional items of INR 95.31 million compared to INR 85.62 million reported a year ago. Net profit was INR 51.5 million or INR 4.68 per basic and diluted share before extraordinary items compared to net profit of INR 71.24 million or INR 6.47 per basic and diluted share before extraordinary items reported a year ago. Net sales were INR 548.01 million compared to INR 443.57 million reported a year ago.
For the year, on standalone basis, the company reported profit from operations before other income, finance costs and exceptional items of INR 351.98 million compared to INR 276.81 million reported a year ago. Net profit was INR 192.6 million or INR 17.49 per basic and diluted share before extraordinary items compared to net profit of INR 216.9 million or INR 19.7 per basic and diluted share before extraordinary items reported a year ago. Net sales were INR 2,024.78 million compared to INR 1,645.2 million reported a year ago.
For the year, on consolidated basis, the company reported profit from operations before other income, finance costs and exceptional items of INR 351.74 million compared to INR 272.29 million reported a year ago. Net profit was INR 192.11 million or INR 17.62 per basic and diluted share before extraordinary items compared to net profit of INR 211.7 million or INR 19.63 per basic and diluted share before extraordinary items reported a year ago. Net sales were INR 2,105.87 million compared to INR 1,678.04 million reported a year ago.
The board of directors recommended a dividend of INR 3.00 per equity share of INR 10.00 each, subject to approval of shareholders for the financial year 2011-12.
The company announced the induction of Shri Shailendra Raj Mehta, as an additional director in the capacity of the non executive, independent director on the board with immediate effect.
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
Poly Medicure Limited Announces Unaudited Standalone Fourth Quarter and Full Year and Audited Consolidated Earnings Results for the Full Year March 31, 2012; Recommends Dividend for the Fiscal 2012; Announces Induction of Shri Shailendra Raj Mehta as an Additional Director in the Capacity of Non Executive, Independent Director on the Board
POLY MEDICURE LIMITED 
